Quick Answer
Eledon Pharmaceuticals, Inc. reported Total Assets of $169.01 million for fiscal year 2025.
Eledon Pharmaceuticals, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $169.01M | -4.7% |
| 2024 | $177.41M | +99.2% |
| 2023 | $89.07M | -4.0% |
| 2022 | $92.79M | -45.6% |
| 2021 | $170.55M | -13.5% |
| 2020 | $197.19M | +1703.9% |
| 2019 | $10.93M | -35.8% |
| 2018 | $17.03M | -18.5% |
| 2017 | $20.89M | +1646.8% |
| 2016 | $1.20M | -98.2% |
| 2015 | $67.97M | -36.9% |
| 2014 | $107.74M | +233.7% |
| 2013 | $32.29M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $129.86M | +13.3% | -10.4% |
| June 30, 2025 | $144.91M | +20.3% | -10.2% |
| March 31, 2025 | $161.31M | +99.6% | -9.1% |
| December 31, 2024 | $177.41M | +99.2% | +54.8% |
| September 30, 2024 | $114.58M | +19.3% | -4.9% |
| June 30, 2024 | $120.48M | +12.8% | +49.1% |
| March 31, 2024 | $80.82M | -1.8% | -9.3% |
| December 31, 2023 | $89.07M | -4.0% | -7.3% |
- Eledon Pharmaceuticals, Inc. showed a decrease of -4.7% in Total Assets compared to the prior fiscal year.
- Over the 2013–2025 period, Eledon Pharmaceuticals, Inc.’s total assets has grown by 423.5% (from $32.29 million to $169.01 million).
- The most recent figure is from Eledon Pharmaceuticals, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 19, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: